BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

977 related articles for article (PubMed ID: 27665362)

  • 1. Upstaging and survival after robotic-assisted thoracoscopic lobectomy for non-small cell lung cancer.
    Toosi K; Velez-Cubian FO; Glover J; Ng EP; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
    Surgery; 2016 Nov; 160(5):1211-1218. PubMed ID: 27665362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer.
    Licht PB; Jørgensen OD; Ladegaard L; Jakobsen E
    Ann Thorac Surg; 2013 Sep; 96(3):943-9; discussion 949-50. PubMed ID: 23684159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lobectomy for Non-Small Cell Lung Cancer by Video-Assisted Thoracic Surgery: Effects of Cumulative Institutional Experience on Adequacy of Lymphadenectomy.
    Lee PC; Kamel M; Nasar A; Ghaly G; Port JL; Paul S; Stiles BM; Andrews WG; Altorki NK
    Ann Thorac Surg; 2016 Mar; 101(3):1116-22. PubMed ID: 26654728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propensity-score adjusted comparison of pathologic nodal upstaging by robotic, video-assisted thoracoscopic, and open lobectomy for non-small cell lung cancer.
    Kneuertz PJ; Cheufou DH; D'Souza DM; Mardanzai K; Abdel-Rasoul M; Theegarten D; Moffatt-Bruce SD; Aigner C; Merritt RE
    J Thorac Cardiovasc Surg; 2019 Nov; 158(5):1457-1466.e2. PubMed ID: 31623811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of unexpected and expected pathologic N1 non-small cell lung cancer.
    Shin S; Kim HK; Choi YS; Kim K; Kim J; Shim YM
    Ann Thorac Surg; 2013 Sep; 96(3):969-75; discussion 975-6. PubMed ID: 23916803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.
    Osarogiagbon RU; Allen JW; Farooq A; Berry A; O'Brien T
    Ann Thorac Surg; 2011 May; 91(5):1486-92. PubMed ID: 21524460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph Node Assessment and Impact on Survival in Video-Assisted Thoracoscopic Lobectomy or Segmentectomy.
    Zhou H; Tapias LF; Gaissert HA; Muniappan A; Wright CD; Wain JC; Donahue DM; Morse CR; Mathisen DJ; Lanuti M
    Ann Thorac Surg; 2015 Sep; 100(3):910-6. PubMed ID: 26165483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A standardized technique of systematic mediastinal lymph node dissection by video-assisted thoracoscopic surgery (VATS) leads to a high rate of nodal upstaging in early-stage non-small cell lung cancer.
    Reichert M; Steiner D; Kerber S; Bender J; Pösentrup B; Hecker A; Bodner J
    Surg Endosc; 2016 Mar; 30(3):1119-25. PubMed ID: 26169635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobe-specific mediastinal nodal dissection is sufficient during lobectomy by video-assisted thoracic surgery or thoracotomy for early-stage lung cancer.
    Shapiro M; Kadakia S; Lim J; Breglio A; Wisnivesky JP; Kaufman A; Lee DS; Flores RM
    Chest; 2013 Nov; 144(5):1615-1621. PubMed ID: 23828253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node evaluation achieved by open lobectomy compared with thoracoscopic lobectomy for N0 lung cancer.
    Merritt RE; Hoang CD; Shrager JB
    Ann Thorac Surg; 2013 Oct; 96(4):1171-1177. PubMed ID: 23915591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodal upstaging evaluation in NSCLC patients treated by robotic lobectomy.
    Zirafa C; Aprile V; Ricciardi S; Romano G; Davini F; Cavaliere I; Alì G; Fontanini G; Melfi F
    Surg Endosc; 2019 Jan; 33(1):153-158. PubMed ID: 29943062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten Years' Experience in Robotic-Assisted Thoracic Surgery for Early Stage Lung Cancer.
    Casiraghi M; Galetta D; Borri A; Tessitore A; Romano R; Diotti C; Brambilla D; Maisonneuve P; Spaggiari L
    Thorac Cardiovasc Surg; 2019 Oct; 67(7):564-572. PubMed ID: 29605962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of thoracoscopic lobectomy for patients with clinical N0 and pathologic N2 non-small cell lung cancer.
    Zhong C; Yao F; Zhao H
    Ann Thorac Surg; 2013 Mar; 95(3):987-92. PubMed ID: 23261117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of insurance type on perioperative outcomes after robotic-assisted pulmonary lobectomy for lung cancer.
    Deol PS; Sipko J; Kumar A; Tsalatsanis A; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
    Surgery; 2019 Aug; 166(2):211-217. PubMed ID: 31202473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis.
    Yang CF; Kumar A; Gulack BC; Mulvihill MS; Hartwig MG; Wang X; D'Amico TA; Berry MF
    J Thorac Cardiovasc Surg; 2016 May; 151(5):1380-8. PubMed ID: 26874598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival after lobectomy for non-small cell lung cancer by video-assisted thoracic surgery versus thoracotomy.
    Lee PC; Nasar A; Port JL; Paul S; Stiles B; Chiu YL; Andrews WG; Altorki NK
    Ann Thorac Surg; 2013 Sep; 96(3):951-60; discussion 960-1. PubMed ID: 23866808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
    Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robotic lobectomy for non-small cell lung cancer (NSCLC): long-term oncologic results.
    Park BJ; Melfi F; Mussi A; Maisonneuve P; Spaggiari L; Da Silva RK; Veronesi G
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):383-9. PubMed ID: 22104677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.
    Darling GE; Allen MS; Decker PA; Ballman K; Malthaner RA; Inculet RI; Jones DR; McKenna RJ; Landreneau RJ; Rusch VW; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):662-70. PubMed ID: 21335122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of predictive factors for postoperative survival for non small cell lung carcinoma patients with unexpected mediastinal lymph nodes metastasis.
    Wang S; Zhou W; Zhang H; Zhao M; Chen X
    Thorac Cardiovasc Surg; 2014 Mar; 62(2):126-32. PubMed ID: 23585223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.